SKBA Capital Management’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Sell
164,740
-19,500
-11% -$47.7K 0.06% 75
2026
Q1
$466K Buy
184,240
+4,200
+2% +$10.8K 0.06% 73
2025
Q4
$601K Buy
180,040
+95,760
+114% +$340K 0.09% 71
2025
Q3
$323K Hold
84,280
0.04% 79
2025
Q2
$362K Sell
84,280
-400
-0.5% -$1.61K 0.05% 76
2025
Q1
$333K Buy
84,680
+27,000
+47% +$128K 0.05% 76
2024
Q4
$293K Buy
57,680
+44,680
+344% +$257K 0.05% 72
2024
Q3
$92.3K Buy
+13,000
New +$82.9K 0.01% 76

Other funds holding CLVT

SKBA Capital Management's CLVT Position: Q2 2026 in Review

SKBA Capital Management reduced its Clarivate (CLVT) stake by 11% in Q2 2026, selling an estimated $47.7K and leaving 164,740 shares worth $356K. The position accounts for 0.06% of the portfolio, ranked #75.

SKBA Capital Management first reported a position in CLVT in Q3 2024 and has held it in 8 quarters since. The position peaked at $601K in Q4 2025. 243 funds tracked by Wall St. Rank hold CLVT as of Q2 2026.

  • SKBA Capital Management held 164,740 shares of Clarivate worth $356K as of Q2 2026.
  • SKBA Capital Management sold 19,500 Clarivate shares in Q2 2026, an estimated $47.7K.
  • Clarivate made up 0.06% of SKBA Capital Management's portfolio in Q2 2026, its #75 holding.
  • SKBA Capital Management first reported a position in Clarivate in Q3 2024 and has held it in 8 quarters since.
  • SKBA Capital Management's Clarivate position peaked at $601K in Q4 2025.
  • 243 funds tracked by Wall St. Rank held Clarivate as of Q2 2026.

Based on SKBA Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.